Speakers
AKNAR CALABRICH
Dr. Calabrich is graduated in Medicine at the Federal University of Bahia, made medical residency in clinics at the University of São Paulo (USP) and in clinical oncology at Sírio Libanês Hospital. She is a specialist in cancerology by the Brazilian Society of Clinical Oncology, and member of the American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO). Currently, is involved in the treatment of lung cancer, gynecological tumors and central nervous system tumors.
CATHERINE ALIX PANABIÈRES
Dr. Alix-Panabières received her PhD degree in 1998 at the University Louis Pasteur, in Strasbourg, France. In 1999, she moved to Montpellier where she did a postdoctoral research at the University Medical Centre of Montpellier, France. During this last decade, she has focused on optimizing new techniques of enrichment and detection of viable disseminating tumor cells in patients with solid tumors. She is the expert for the EPISPOT technology that is used to detect viable tumor cells in the peripheral blood and the bone marrow of cancer patients. In 2010, she achieved getting a permanent position at the Hospital and at the Faculty of Medicine of Montpellier (MCU-PH), a wonderful mixture of giving teaching lessons to medical students on Cancer Biology in combination of developing this field of tumor cell dissemination at the hospital for the cancer patients, leading strongly translational clinical research. As an associate professor, she recently became the new director of the Laboratory of Rare Human Circulating Cells (LCCRH) in the Department of Cell & Tissue Biopathology of tumors. She has authored or co-authored >60 scientific publications in this field during the last years including 10 book chapters, received various prizes and participates of important European projects in this area.
ELISA FERREIRA
Elisa N. Ferreira has a broad background in Molecular Biology and Genomics with focus on cancer genomics. Currently, she is Scientific Researcher at the Research and Development section of Fleury Medicina e Saúde Group. She has a degree in Biological Sciences from the University of São Paulo and obtained her PhD in Genetics from the same university. She has been working in hospital and health care industry for the past years and is involved in oncology research projects and the development of new diagnostic methods based on next generation sequencing (exome, genome, transcriptome), real time PCR and digital PCR.
PATRICIA PINTOR REIS
Dr. Reis performed her MSc and PhD at São Paulo State University (UNESP). During her Post-Doctoral fellowship at UHN under Dr. Kamel-Reid's supervision, she was directly involved in a strong Translational Oncology Program on Head and Neck Cancer and my role was to oversee the development of molecular profiling analyses for biomarker identification in head and neck cancer. This led her to occupy the position of Scientific Associate in Professor Kamel-Reid's laboratory (2005-2011). In 2011, she moved back to Brazil being admitted as Assistant Professor at the Faculty of Medicine (FMB), UNESP. Recently, she became Associate Professor at FMB-UNESP. In this institution, she lead an independent translational research program in Lung Cancer. Her team's goals are to identify robust biomarkers useful to improve patient diagnosis, prognosis and/or treatment, focusing on transcriptome/RNA regulation.
ANDRÉ LAVORATO
Dr. Lavorato is graduated in Biomedicine (2009), obtained his MSc and PhD degrees in Science, Oncology area, at A. C. Camargo Cancer Center (2011 and 2016). He has worked with molecular diagnosis of infectious diseases at the Genome Center, and has skills in Pathology, Oncology and Molecular Biology. Currently acts a field application specialist at Bio-Rad Laboratories.
DANIELLE QUEIROZ CALCAGNO
Dr. Queiroz Calcagno received her B.S. in Biomedicine (2005), MSc. and PhD. in Genetics and Molecular Biology (2006 and 2010, respectively) from Universidade Federal do Pará. She did her postdoctoral degree in Genetics Division Lab at Universidade Federal de São Paulo (2010-2013). Currently, she is professor at Universidade Federal do Pará, and has fellowship of research productivity (PQ) 2 granted by the National Council for Scientific and Technologica (CNPq). In addition, she develops activities as tutor in the Multiprofessional Residency Program in Health, supervising biomedicine residents in Oncology at Hospital Universitário João de Barros Barreto. She has research focus on liquid biopsy, developing clinical follow-up projects for circulating tumor DNA from gastric and breast cancer patients. In 2018, she participated in the theoretical and practical course "Liquid Biopsies" organized by the European Molecular Biology Laboratory - EMBL (Heidelberg, Germany).
LUDMILLA CHINEN
Dr. Ludmilla T. D. Chinen is currently a Senior Researcher at A. C. Camargo Cancer Center. She is graduated in Biochemistry/Pharmacy at the Federal University of Goiás (1998), MSc in Tropical Medicine (Immunology) at the Federal University of Goiás (2001) and PhD in Microbiology and Immunology (2005) at Federal University of São Paulo. She was manager of a Pharmaceutical Company (2005-2006) and Biochemistry/Pharmacology professor at a private university (2005-2006). Her present research focuses are Circulating Tumor Cells (CTCs), their role in tumor metastasis and their clinical significance. Recently, she received the commendation of pharmaceutical merit, an award from the Regional Pharmacy Council aimed to professionals with recognized excellence in teaching, assistance or research.
SUSANA GARCÍA-SILVA
In 2002, Susana García-Silva received her doctorate in Biochemistry from the Autonomous University of Madrid with a job in the laboratory of Dr. Ana Aranda. The work focused on the antagonistic role of nuclear thyroid hormone receptors on the oncogene ras. In 2005, she moved to the laboratory of Dr. Claus Nerlov, first at the headquarters of the European Molecular Biology Laboratory (EMBL) and later at the Center for Regenerative Medicine, MRC-University of Edinburgh (United Kingdom). During this period, her studies focused on the C/EBPs factors and their role in the development of the skin and the mammary gland, as well as their functional interaction with the oncogene ras and cyclin D1. In 2011, she joined the Stem Cell and Cancer Group of the National Center for Oncological Research (CNIO) as a scientific researcher. Her work focused on pancreatic cancer and the role of cancer stem cells in this type of tumor in mouse models. In 2015, she started her studies within the Microenvironment and Metastasis Group led by Dr. Héctor Peinado, also at the CNIO, to investigate the development of new therapies and melanoma diagnostic tools based on tumor exosomes. She is the author of about twenty publications, including reviews and book chapters on cancer stem cells.
BEATRIZ PINTO
Beatriz Pinto obtained her master degree in Genetics. She has 15 years of experience in Bioinformatics working with Next Generation Sequencing, protein sequencing, proteogenomics annotation, and mass spectrometry. She also has experience in programming languages and databases. Nowadays she is a Sequencing Product Specialist, Life Sciences Solutions at Thermo Fisher Scientific.
DIANA NORONHA NUNES
Dr. Nunes obtained her bachelor degree in Biological Sciences at PUC Minas Gerais, MSc in Oncology at Ludwig Institute for Cancer Research-SP, and PhD in Biochemistry and Molecular Biology at University of São Paulo. She was post-doctorate fellow in Oncology at MD Anderson Cancer Center. During her MSc at the Ludwig Institute for Cancer Research, her group was among the first to demonstrate the presence of tumor DNA in body fluids of cancer patients. Since the end of 2010, she is a Scientific Researcher in the A. C. Camargo Cancer Center, where she has a particular interest in the use of genomics as a tool to study how liquid biopsies can be useful in identifying biomarkers useful for cancer diagnosis and prognosis. In this sense, her group focused on the characterization of extracellular vesicles and published a new methodology for total transcriptome profiling of plasma-derived EVs by NGS from limited quantities of patient-derived samples, which enables the unbiased characterization of the complete RNA cargo in a single library preparation step. A special interest of her group is also the use of cell-free tumor derived DNA as a tool to survey the patient’s response to neoadjuvant chemotherapy.
MIRIAM JASIULIONIS
Associate Professor at the Department of Pharmacology, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo since 2006. She earned her B.D. in Biomedical Sciences at EPM (1990), M.Sc. degree in Biochemistry at EPM (1993), PhD in Cellular Biology at Ludwig Institute for Cancer Research – SP / UNIFESP (1997), and Postdoc in Cellular Biology (1998-1999) and Immunology (2002-2006) at UNIFESP. In 2006 and 2009, she did short trainings in Peter Jones’ Lab at the University of Southern California, Los Angeles. She had established cellular models for studying malignant transformation and tumor progression, specially melanoma and astrocytoma, as well an in vivo model to evaluate the tumor take associated with acute inflammation. The main aim of her group is to understand the relationship among cellular stress, epigenetic alterations and malignant transformation. Currently, she has focused on an integrative view of the molecular alterations, including data from the transcriptome, methylome, chromatin proteome, miRNA and lncRNA profiles, associated with early and late stages of melanoma progression. These findings have been validated in human samples and resulted in the identification of several independent prognostic biomarkers for melanoma patients’ survival.
See lectures abstracts. Click here.
OUR SPONSORS
